Innovative Eyewear Inc (LUCY)
6.56
-0.16
(-2.38%)
USD |
NASDAQ |
Nov 22, 16:00
6.68
+0.12
(+1.83%)
After-Hours: 20:00
Innovative Eyewear Cash from Financing (Quarterly): 5.034M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.034M |
| June 30, 2024 | 5.196M |
| March 31, 2024 | -0.076M |
| December 31, 2023 | -0.2851M |
| September 30, 2023 | -0.0203M |
| June 30, 2023 | 5.609M |
| March 31, 2023 | 1.358M |
| December 31, 2022 | -0.203M |
| Date | Value |
|---|---|
| September 30, 2022 | 5.970M |
| June 30, 2022 | 0.5135M |
| March 31, 2022 | 0.6756M |
| December 31, 2021 | 0.4496M |
| September 30, 2021 | 0.4464M |
| June 30, 2021 | 0.2582M |
| March 31, 2021 | 0.2312M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.2851M
Minimum
Dec 2023
5.970M
Maximum
Sep 2022
1.677M
Average
0.4496M
Median
Dec 2021
Cash from Financing (Quarterly) Benchmarks
| The Cooper Companies Inc | -87.60M |
| Staar Surgical Co | 1.615M |
| OrthoPediatrics Corp | 58.52M |
| NexGel Inc | 1.214M |
| Perspective Therapeutics Inc | 0.628M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.400M |
| Cash from Investing (Quarterly) | -4.987M |
| Free Cash Flow | -6.335M |
| Free Cash Flow Per Share (Quarterly) | -0.8587 |
| Free Cash Flow to Equity (Quarterly) | -1.491M |
| Free Cash Flow Yield | -94.80% |